Related Experiment Videos
[Effect of two extracted fraction from Lycopus lucidus on coagulation function]
1Institute of Medicinal Plant, Chinese Academy of Medical Sciences, Beijing 100094.
Zhong Yao Cai = Zhongyaocai = Journal of Chinese Medicinal Materials
|October 24, 2001
Summary
Two Lycopus lucidus fractions, F04-A and F04-B, effectively inhibit platelet aggregation and prolong blood coagulation time in vivo and in vitro. F04-A shows stronger activity, potentially aiding circulation and blood stasis removal.
Area of Science:
- Pharmacology
- Natural Products Chemistry
Context:
- Lycopus lucidus, a traditional medicinal herb, has been investigated for its bioactive compounds.
- Understanding the hemostatic properties of plant extracts is crucial for developing novel therapeutic agents.
Purpose:
- To identify and characterize the specific fractions of Lycopus lucidus that exhibit significant effects on blood coagulation.
- To evaluate the in vitro and in vivo efficacy of these fractions in modulating platelet aggregation and coagulation parameters.
Summary:
- Two fractions, F04-A and F04-B, derived from Lycopus lucidus, demonstrated potent inhibition of platelet aggregation in both in vitro and in vivo models.
- These fractions also significantly prolonged blood coagulation time in mice, indicating an anticoagulant effect.
- Notably, neither fraction impacted bleeding time, suggesting a specific action on coagulation pathways rather than general hemostasis.
Impact:
- The findings suggest that F04-A and F04-B possess distinct hemostatic properties, with F04-A exhibiting superior activity.
- F04-A is proposed as a key active fraction from Lycopus lucidus for promoting blood circulation and resolving blood stasis.
- This research provides a scientific basis for the traditional use of Lycopus lucidus in managing circulatory disorders.